An iminosugar with potent inhibition of dengue virus infection in vivo-Reference-Cited by-同舟云学术

An iminosugar with potent inhibition of dengue virus infection in vivo

Published:2013-04 Issue:1 Volume:98 Page:35-43
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Perry Stuart T.,Buck Michael D.,Plummer Emily M.,Penmasta Raju A.,Batra Hitesh,Stavale Eric J.,Warfield Kelly L.,Dwek Raymond A.,Butters Terry D.,Alonzi Dominic S.,Lada Steven M.,King Kevin,Klose Brennan,Ramstedt Urban,Shresta Sujan

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference33 articles.

1. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification;Balsitis;PLoS Pathog.,2010

2. Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs;Block;Antiviral Chem. Chemother.,2001

3. Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo;Chang;Antiviral Res.,2011

4. Competitive inhibitor of cellular alpha-glucosidases protects mice from lethal dengue virus infection;Chang;Antiviral Res.,2011

5. Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses;Chang;Antimicrob. Agents Chemother.,2009

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epi-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses;ACS Central Science;2024-07-25

2. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series;Current Computer-Aided Drug Design;2023-08-23

3. Dengue Virus: Molecular Biology and Recent Developments in Control Strategies, Prevention, Management, and Therapeutics;Journal of Pharmacology and Pharmacotherapeutics;2023-06

4. Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines;Current Treatment Options in Infectious Diseases;2023-04-18

5. Host Cell Targets for Unconventional Antivirals against RNA Viruses;Viruses;2023-03-17